The first Black woman to graduate from the Duke School of Medicine in 1972, Jean Spaulding went on to help lead Duke Health as an administrator, making primary health care accessible to low-wealth residents across Durham and beyond.

A team of Duke researchers describe a synthetic molecule that mimics the effects of compounds in the saliva of blood-sucking critters that can also be swiftly reversed, enabling clotting to resume when needed after treatment.

Researchers at Duke University School of Medicine have secured a contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for up to $6 million

Discovery paves the way for more effective cancer treatments that benefit a larger group of patients.

Medical students at Duke University School of Medicine have selected selected Jamie Fox, MD; Erica Odukoya, MD; and Jenny Van Kirk, MD; for the 2024 annual Golden Apple Awards.   

Duke Health leaders have selected seven high-potential innovation projects to be implemented as part of the Duke Institute for Health Innovation (DIHI)’s annual call for project ideas.

Duke Cancer Institute is rewriting the narrative for patients with bladder and urothelial cancer by pursuing innovative combination therapy.

After decades of decline, heart failure mortality is climbing, with a dramatic rise in heart failure deaths among adults age 45 and younger.

A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report.